CD4+ T cell receptor recognizing Hepatitis C Virus-derived peptides (HCV-specific CD4+ TCR) (HCV-specific CD4+ TCR)

CD4+ T cell receptors (TCRs) recognizing Hepatitis C Virus (HCV)-derived peptides are specialized protein complexes on the surface of helper T lymphocytes that identify viral antigens presented by Major Histocompatibility Complex (MHC) class II molecules (Source: Schulze Zur Wiesch et al., Journal of Experimental Medicine, 2012). These receptors play a pivotal role in the immune system's ability to control and clear HCV infection by initiating signaling cascades that lead to the production of critical cytokines, such as interferon-gamma and interleukin-2 (Source: Grakoui et al., Science, 2003). A robust and diverse CD4+ TCR response is strongly correlated with spontaneous viral clearance, whereas a weak or narrow response often leads to chronic infection and progressive liver disease, including cirrhosis and hepatocellular carcinoma (Source: Lauer et al., Journal of Virology, 2002). In the context of drug development, these TCRs are the primary targets for T-cell-based vaccines, such as the ChAd3-NSmut/MVA-NSmut prime-boost regimen, and experimental adoptive cell therapies aimed at restoring or enhancing the host's anti-viral immunity (Source: Swadling et al., Science Translational Medicine, 2014). Therapeutic interventions seek to expand the population of T cells bearing these specific receptors or to improve their functional sensitivity to viral peptides. However, challenges such as viral mutational escape and the potential for immune-mediated tissue damage must be carefully managed in clinical applications (Source: Walker, Nature, 2010).

Other names

Hepatitis C virus-specific CD4+ T-cell receptorMHC class II-restricted HCV-specific TCRHCV-specific TCRCD4+ TCR recognizing HCV peptides

Vaccines or adoptive therapies targeting these receptors aim to induce or restore the activation of HCV-specific CD4+ T cells. Upon binding to viral peptides presented by MHC class II, these TCRs trigger the release of Th1 cytokines (IFN-gamma, IL-2) and provide essential help to CD8+ cytotoxic T cells and B cells, ultimately leading to the suppression of viral replication and clearance of infected hepatocytes (Source: Grakoui et al., Science, 2003; Shoukry et al., Journal of Experimental Medicine, 2003).